Hans‐Jörg Breyholz
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 17
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 4
- Oncology top 5%
- Peptidase Inhibition and Analysis 19
-
- Radiopharmaceutical Chemistry and Applications 5
- Medical Imaging Techniques and Applications 3
- Neurology top 10%
-
- Click Chemistry and Applications 5
-
- Receptor Mechanisms and Signaling 5
-
- Neuropeptides and Animal Physiology 4
- Co-authors
- Michael SchäfersKlaus KopkaStefan WagnerOtmar SchoberAndreas FaustBodo LevkauCarsten HöltkeBurkhard Riemann
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Hans‐Jörg Breyholz
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Cancer Research 490
- Immunology and Allergy 116
- Oncology 475
- Radiology, Nuclear Medicine and Imaging 337
- Neurology 70
Countries citing papers authored by Hans‐Jörg Breyholz
This map shows the geographic impact of Hans‐Jörg Breyholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Jörg Breyholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Jörg Breyholz more than expected).
Fields of papers citing papers by Hans‐Jörg Breyholz
This network shows the impact of papers produced by Hans‐Jörg Breyholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Jörg Breyholz. The network helps show where Hans‐Jörg Breyholz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans‐Jörg Breyholz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2022 | 22 | |
| 3 | 2021 | 59 | |
| 4 | 2017 | 8 | |
| 5 | 2016 | 124 | |
| 6 | Dual Time Point PET/CT Acquisition Using Ga-68-PSMA-Radioligand | 2015 | 4 |
| 7 | 2012 | 7 | |
| 8 | 2011 | 24 | |
| 9 | 2011 | 47 | |
| 10 | 2010 | 57 | |
| 11 | 2009 | 12 | |
| 12 | 2009 | 1 | |
| 13 | 2009 | 28 | |
| 14 | 2008 | 50 | |
| 15 | 2006 | 61 | |
| 16 | 2006 | 61 | |
| 17 | 2005 | 10 | |
| 18 | 2005 | 22 | |
| 19 | 2004 | 59 | |
| 20 | 2001 | 0 |
About Hans‐Jörg Breyholz
Hans‐Jörg Breyholz is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (19 papers), Protease and Inhibitor Mechanisms (17 papers), Click Chemistry and Applications (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Receptor Mechanisms and Signaling (5 papers), Cell Adhesion Molecules Research (4 papers), Neuropeptides and Animal Physiology (4 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Cancer Research (490 citations), Immunology and Allergy (116 citations) and Oncology (475 citations). Hans‐Jörg Breyholz has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael Schäfers, Klaus Kopka, Stefan Wagner, Otmar Schober, Andreas Faust, Bodo Levkau, Carsten Höltke, Burkhard Riemann, Marilyn P. Law and Sven Hermann. Their work appears in journals such as Circulation, Radiology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.